{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:32:53Z","timestamp":1760189573185},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,12]]},"DOI":"10.18632\/oncotarget.19211","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T21:32:02Z","timestamp":1499895122000},"page":"76204-76213","source":"Crossref","is-referenced-by-count":13,"title":["Germline variations at <i>JAK2<\/i>, <i>TERT<\/i>, <i>HBS1L-MYB<\/i> and <i>MECOM<\/i> and the risk of myeloproliferative neoplasms in Taiwanese population"],"prefix":"10.18632","volume":"8","author":[{"given":"Yi-Hao","family":"Chiang","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Cheng","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Chau","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Huang","sequence":"additional","affiliation":[{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Chia","family":"Cheng","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-I","family":"Cheng","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Hsinchu, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai-Wen","family":"Su","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb Gon-Shen","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan"},{"name":"Institute of Molecular and Cellular Biology, National Tsing-Hua University, Hsinchu, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnson","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fang","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chih","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruey-Kuen","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chien","family":"Chou","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-Hong","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan"},{"name":"Laboratory of Good Clinical Research Center, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan"},{"name":"Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Yeh","family":"Kuo","sequence":"additional","affiliation":[{"name":"Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1038\/bcj.2015.64","article-title":"Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis","volume":"5","author":"Tefferi","year":"2015","journal-title":"Blood Cancer J"},{"key":"2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1200\/JCO.2010.29.8711","article-title":"Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies","volume":"29","author":"Vainchenker","year":"2011","journal-title":"J Clin Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajh.24221","article-title":"Myeloproliferative neoplasms: a decade of discoveries and treatment advances","volume":"91","author":"Tefferi","year":"2016","journal-title":"Am J Hematol"},{"key":"4","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","article-title":"Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms","volume":"123","author":"Skoda","year":"2014","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Bagienski","year":"2013","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Hinton","year":"2013","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1038\/bcj.2015.21","article-title":"Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis","volume":"5","author":"Kuo","year":"2015","journal-title":"Blood Cancer J"},{"key":"8","doi-asserted-by":"publisher","first-page":"52614","DOI":"10.18632\/oncotarget.10376","article-title":"CALR mutation characterization in myeloproliferative neoplasms","volume":"7","author":"Gomez-Casares","year":"2016","journal-title":"Oncotarget"},{"key":"9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms","volume":"41","author":"Cross","year":"2009","journal-title":"Nat Genet"},{"key":"10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.342","article-title":"A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms","volume":"41","author":"Stone","year":"2009","journal-title":"Nat Genet"},{"key":"11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ng.341","article-title":"A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms","volume":"41","author":"Kralovics","year":"2009","journal-title":"Nat Genet"},{"key":"12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2040620713489144","article-title":"Inherited predisposition to myeloproliferative neoplasms","volume":"4","author":"Cross","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"13","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1182\/blood-2009-08-236448","article-title":"The JAK2 46\/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms","volume":"115","author":"Harrison","year":"2010","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/leu.2009.110","article-title":"The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera","volume":"23","author":"Prchal","year":"2009","journal-title":"Leukemia"},{"key":"15","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/leu.2014.48","article-title":"The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms","volume":"28","author":"Olafsson","year":"2014","journal-title":"Leukemia"},{"key":"16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ajh.23842","article-title":"Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms","volume":"89","author":"Kralovics","year":"2014","journal-title":"Am J Hematol"},{"key":"17","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1038\/ncomms7691","article-title":"Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms","volume":"6","author":"Waghorn","year":"2015","journal-title":"Nat Commun"},{"key":"18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/bjh.14041","article-title":"TERT rs2736100 A>C SNP and JAK2 46\/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients","volume":"174","author":"Georgescu","year":"2016","journal-title":"Br J Haematol"},{"key":"19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/humu.21019","article-title":"High-resolution melting analysis (HRMA): more than just sequence variant screening","volume":"30","author":"den Dunnen","year":"2009","journal-title":"Hum Mutat"},{"key":"20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2009.07.002","article-title":"Detection of the JAK2 V617F missense mutation by high resolution melting analysis and its validation","volume":"408","author":"Liu","year":"2009","journal-title":"Clin Chim Acta"},{"key":"21","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.cca.2010.08.020","article-title":"Rapid detection of JAK2 V617F mutation using high-resolution melting analysis with LightScanner platform","volume":"411","author":"Qian","year":"2010","journal-title":"Clin Chim Acta"},{"key":"22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2353\/jmoldx.2009.080110","article-title":"High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms","volume":"11","author":"Martinez-Lopez","year":"2009","journal-title":"J Mol Diagn"},{"key":"23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cca.2014.11.011","article-title":"Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysis","volume":"440","author":"Hsieh","year":"2015","journal-title":"Clin Chim Acta"},{"key":"24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12185-012-1169-8","article-title":"The JAK2 46\/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients","volume":"96","author":"Guan","year":"2012","journal-title":"Int J Hematol"},{"key":"25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/1055-9965.EPI-15-0805","article-title":"Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a synergism between cytoreductive therapy and the common TERT polymorphism rs2736100","volume":"25","author":"Andrikovics","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2015-06-652941","article-title":"Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms","volume":"128","author":"Zehnder","year":"2016","journal-title":"Blood"},{"key":"27","doi-asserted-by":"publisher","first-page":"9550","DOI":"10.18632\/oncotarget.7072","article-title":"A TET2 rs3733609 C\/T genotype is associated with predisposition to the myeloproliferative neoplasms harboring JAK2(V617F) and confers a proliferative potential on erythroid lineages","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2350-13-6","article-title":"The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population","volume":"13","author":"Ohyashiki","year":"2012","journal-title":"BMC Med Genet"},{"key":"29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12863-014-0147-y","article-title":"Genetic association between germline JAK2 polymorphisms and myeloproliferative neoplasms in Hong Kong Chinese population: a case-control study","volume":"15","author":"Chu","year":"2014","journal-title":"BMC Genet"},{"key":"30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijge.2012.07.002","article-title":"JAK2 V617F mutation in adult Taiwanese patients with essential thrombocythemia: more prevalent in old patients and correlated with higher hemoglobin level and higher leukocyte count","volume":"7","author":"Cheng","year":"2013","journal-title":"Int J Gerontol"},{"key":"31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2144\/000112028","article-title":"High-throughput SNP genotyping by single-tube PCR with Tm-shift primers","volume":"39","author":"Germer","year":"2005","journal-title":"BioTechniques"},{"key":"32","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2337\/db08-0377","article-title":"Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population","volume":"57","author":"Chuang","year":"2008","journal-title":"Diabetes"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T17:52:53Z","timestamp":1596995573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,12]]},"references-count":32,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2017,9,29]]}},"alternative-id":["19211","29100304"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.19211","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,12]]}}}